Edwards Lifesciences Corporation
EW · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $290 | $332 | $356 | $386 |
| Dep. & Amort. | $39 | $38 | $37 | $43 |
| Deferred Tax | -$18 | -$21 | -$24 | -$99 |
| Stock-Based Comp. | $41 | $38 | $40 | $51 |
| Change in WC | $84 | -$142 | -$151 | -$463 |
| Other Non-Cash | $138 | $46 | $22 | -$45 |
| Operating Cash Flow | $574 | $290 | $280 | -$128 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$58 | -$49 | -$56 | -$54 |
| Net Acquisitions | $0 | $3 | -$3 | -$298 |
| Inv. Purchases | -$1,031 | -$630 | -$647 | -$391 |
| Inv. Sales/Matur. | $670 | $594 | $846 | $268 |
| Other Inv. Act. | -$9 | -$90 | -$54 | -$102 |
| Investing Cash Flow | -$428 | -$172 | $85 | -$577 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $57 | $50 | $0 |
| Stock Repurch. | $157 | -$6 | -$259 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$897 | $1 | -$50 | $29 |
| Financing Cash Flow | -$740 | $53 | -$258 | $29 |
| Forex Effect | -$1 | -$30 | -$18 | $51 |
| Net Chg. in Cash | -$595 | $141 | $90 | -$625 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,290 | $3,149 | $3,059 | $3,683 |
| End Cash | $2,695 | $3,290 | $3,149 | $3,059 |
| Free Cash Flow | $516 | $241 | $224 | -$177 |